At the 13th EURETINA Congress yesterday, results were presented from a cohort study evaluating the use of a minimally invasive retrobulbar episcleral brachytherapy device developed by Salutaris Medical Devices, Ltd. (SalutarisMD®) to treat wet AMD (age-related macular degeneration), the leading cause of vision loss and blindness.
Help employers find you! Check out all the jobs and post your resume.
